Aethlon Medical, Inc. income statement AEMD

Annual Quarterly

It recorded a net loss of $7.2 million. Diluted earnings per share were -$10.61. Across the 7 fiscal years shown, revenue grew from $392,073 in fiscal 2017 to $574,245 in fiscal 2023, about 6.6% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2026 Mar 31, 2026	FY 2025 Mar 31, 2025	FY 2024 Mar 31, 2024	FY 2023 Mar 31, 2023	FY 2022 Mar 31, 2022	FY 2021 Mar 31, 2021	FY 2020 Mar 31, 2020	FY 2018 Mar 31, 2019	FY 2018 Mar 31, 2018	FY 2017 Mar 31, 2017
Revenue	—	—	0 -100.0%	1 +95.2%	0 -55.4%	1 +1.4%	1	0 -41.4%	0 -61.8%	0 -55.8%
Research and development	2 -13.6%	2 -12.2%	3 -8.2%	3 +17.3%	2 +13.0%	2 +123.5%	1	1 +33.1%	1 -12.9%	1 -13.9%
Selling, general and administrative	3 -16.9%	3 -16.9%	4 -12.9%	4 +29.7%	3 +40.6%	2 +58.7%	2	1 +12.2%	1 -6.7%	1 -8.6%
Operating income	-7 +21.9%	-9 +26.1%	-13 -6.2%	-12 -14.2%	-10 -32.1%	-8 -33.1%	-6	-6 +1.6%	-5 +20.8%	-6 -39.1%
Interest income	0	—	—	—	—	—	—	—	—	—
Interest expense	0	—	—	—	—	—	—	—	—	—
Pretax income	-7	—	—	—	—	—	—	—	—	—
Income tax	0	0	0	0	0	0	0	0	0	0
Net income	-7 +46.6%	-13 -9.7%	-12 -1.5%	-12 -15.5%	-10 -32.1%	-8 -23.7%	-6	-6 +14.9%	-6 +21.9%	-7 -49.3%
Basic EPS	-10.61 +87.6%	-85.77 -120.7%	-38.87 -563.3%	-5.86	—	—	—	—	—	—
Diluted EPS	-10.61 +87.6%	-85.77 -120.7%	-38.87 -563.3%	-5.86	—	—	—	—	—	—
Weighted average shares, basic	1 +331.8%	0 -50.3%	0 -84.7%	2	—	—	—	—	—	—
Weighted average shares, diluted	1 +331.8%	0 -50.3%	0 -84.7%	2	—	—	—	—	—	—
Other measures
Depreciation and amortization	0 -4.7%	0 -5.4%	0 +49.1%	0 +94.8%	0 +209.7%	0 +51.5%	0	0 +10.0%	0 +10.0%	0 -15.9%
EBITDA	-7 +22.6%	-9 +26.7%	-12 -5.3%	-12 -13.2%	-10 -31.1%	-8 -33.0%	-6	-6 +1.7%	-5 +20.9%	-6 -39.6%
Interest coverage	-507.49x	—	—	—	—	—	—	—	—	—
Margins
Operating margin	—	—	—	-2,072.05%	-3,542.53%	-1,197.31%	-912.04%	-2,612.53%	-3,228.82%	-1,555.41%
Profit margin	—	—	—	-2,094.89%	-3,540.90%	-1,196.58%	-980.33%	-2,697.75%	-3,795.86%	-1,855.81%
EBITDA margin	—	—	—	-2,030.10%	-3,500.48%	-1,191.25%	-907.99%	-2,597.00%	-3,204.98%	-1,547.15%

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: AEMD (Nasdaq)
Fiscal year ends: March 31
Incorporated in: NV
Headquarters: San Diego, CA
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 882291
Former names: BISHOP EQUITIES INC (until Mar 13, 2000)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.